Pacira BioSciences: Q1 Earnings Insights

Pacira BioSciences PCRX reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Pacira BioSciences missed estimated earnings by 22.89%, reporting an EPS of $0.64 versus an estimate of $0.83.

Revenue was up $38.96 million from the same period last year.

Last quarter the company beat on EPS by $0.07 which was followed by a 4.89% increase in the share price the next day.

Here's a look at Pacira BioSciences's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	0.90	0.65	0.69	0.63
EPS Actual	0.97	0.72	0.77	0.53
Revenue Estimate	155.74M	130.38M	128.01M	119.28M
Revenue Actual	159.19M	127.72M	135.59M	119.03M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar